Clinical Trial

Bone Metabolism in Premenopausal Exercising Women

Study acronym: BeWOMEN
Enrolling by Invitation
View on ClinicalTrials.gov →
Record status
This record was last updated May 8, 2025 (before its estimated December 20, 2025 completion). Its status may not reflect the trial's current state.
Summary
The main goal of this study is to examine how sex hormones and low energy availability affect the concentrations of bone remodelling markers at rest and after a running protocol. The research questions to be addressed are: 1: Does the ovarian hormone profile influence serum bone marker concentrations in women exercising resting and in response to to exercise? 2\. Are there differences in response to low energy availability in bone marker concentrations between eumenorrhoeic female athletes and oral contraceptive users? 3: Is the response of bone markers affected by different exercise stimuli: endurance or aerobic endurance? 4: Do bone markers return to baseline levels after 24 hours of high energy availability diet after 6 days of low energy availability?
Trial Details
NCT Number NCT06961773
Lead Sponsor Universidad Politecnica de Madrid
Conditions Contraception, Bone Metabolism, Low Energy Availability, Eumenorrhea
Enrollment 22 participants
Start Date 2024-12-05
Primary Completion 2025-12-20 (estimated)
Study Completion 2026-06-15 (estimated)
Updated on ClinicalTrials.gov 2025-05-08